105 HLH-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 8 | 7.7 | 1.03× | q = 1.00 | |
| Homogeneous non-metal compounds | 6 | 3.4 | 1.77× | not tested | |
| Lipids and lipid-like molecules | 2 | 1.8 | 1.14× | not tested | |
| Organic acids and derivatives | 1 | 2.4 | 0.41× | not tested | |
| Organic oxygen compounds | 1 | 3.1 | 0.32× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02210 | HEZ | Hexane-1,6-Diol | 2 |
| DB00141 | NAG | N-Acetylglucosamine | 1 |
| DB00338 | — | — | 1 |
| DB00379 | — | — | 1 |
| DB00393 | — | — | 1 |
| DB00499 | — | Flutamide | 1 |
| DB01076 | — | Atorvastatin | 1 |
| DB01097 | — | — | 1 |
| DB02052 | — | Indirubin-3'-monoxime | 1 |
| DB02709 | — | Resveratrol | 1 |
| DB02736 | ACM | Acetamide | 1 |
| DB04216 | — | Quercetin | 1 |
| DB06083 | — | — | 1 |
| DB06732 | — | — | 1 |
| DB07715 | — | Emodin | 1 |
| DB08624 | — | — | 1 |
| DB08995 | — | — | 1 |
| DB11937 | — | Kynurenic Acid | 1 |
| DB12116 | — | Epigallocatechin gallate | 1 |
| DB12255 | — | Vadadustat | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 33 |
| NAmetal | SODIUM ION | 13 |
| V7J | 2-(2,5-dioxopyrrolidin-1-yl)acetamide | 6 |
| ER3metal | ERBIUM (III) ION | 4 |
| ZNmetal | ZINC ION | 4 |
| Kmetal | POTASSIUM ION | 3 |
| A1IS4 | 1-(3-chlorophenyl)-6-[2-(1-oxidanylcyclohexyl)ethynyl]indole-2-carboxylic acid | 2 |
| A1IS5 | 6-[2-(1-oxidanylcyclohexyl)ethynyl]-1-phenyl-indole-2-carboxylic acid | 2 |
| A1IS6 | 5-chloranyl-3-phenyl-1H-indole-2-carboxylic acid | 2 |
| A1IS7 | 4-methyl-6-[2-(1-oxidanylcyclohexyl)ethynyl]-1-phenyl-indole-2-carboxylic acid | 2 |
| A1ISF | 1-(2-phenylethynyl)cyclohexan-1-ol | 2 |
| CAmetal | CALCIUM ION | 2 |
| HGmetal | MERCURY (II) ION | 2 |
| JEF | O-(O-(2-AMINOPROPYL)-O'-(2-METHOXYETHYL)POLYPROPYLENE GLYCOL 500) | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| MV0 | 7-acetyl-4-methoxy-1-benzofuran-3(2H)-one | 2 |
| A1CAO | (5M)-5-(3-amino-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)-2-phenoxybenzene-1-sulfonic acid | 1 |
| BME | BETA-MERCAPTOETHANOL | 1 |
| FEmetal | FE (III) ION | 1 |
| HEZ | HEXANE-1,6-DIOL | 1 |